$MLAB Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in MESA LABORATORIES INC /CO/.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in MESA LABORATORIES INC /CO/. Get notifications about new insider transactions in MESA LABORATORIES INC /CO/ for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 16 2021 | MLAB | MESA LABORATORIES ... | Hall Shannon | Director | Option Exercise | M | 0.00 | 194 | 0 | 0 | |
Jun 16 2021 | MLAB | MESA LABORATORIES ... | Hall Shannon | Director | Buy | M | 0.00 | 194 | 0 | 448 | 254 to 448 (+76.38 %) |
Jun 09 2021 | MLAB | MESA LABORATORIES ... | Sullivan John James | Director | Option Exercise | X | 89.70 | 5,192 | 465,722 | 44,796 | |
Jun 09 2021 | MLAB | MESA LABORATORIES ... | Sullivan John James | Director | Sell | S | 258.19 | 5,192 | 1,340,522 | 24,208 | 29.4 K to 24.2 K (-17.66 %) |
Jun 09 2021 | MLAB | MESA LABORATORIES ... | Sullivan John James | Director | Buy | M | 89.70 | 5,192 | 465,722 | 29,400 | 24.2 K to 29.4 K (+21.45 %) |
Jun 07 2021 | MLAB | MESA LABORATORIES ... | KELLY DAVID M | Director | Option Exercise | X | 142.40 | 90 | 12,816 | 587 | |
Jun 07 2021 | MLAB | MESA LABORATORIES ... | KELLY DAVID M | Director | Option Exercise | X | 142.40 | 90 | 12,816 | 587 | |
Jun 07 2021 | MLAB | MESA LABORATORIES ... | KELLY DAVID M | Director | Option Exercise | X | 122.66 | 200 | 24,532 | 677 | |
Jun 07 2021 | MLAB | MESA LABORATORIES ... | KELLY DAVID M | Director | Option Exercise | X | 122.66 | 200 | 24,532 | 677 | |
Jun 07 2021 | MLAB | MESA LABORATORIES ... | KELLY DAVID M | Director | Option Exercise | X | 97.78 | 200 | 19,556 | 877 | |
Jun 07 2021 | MLAB | MESA LABORATORIES ... | KELLY DAVID M | Director | Option Exercise | X | 97.78 | 200 | 19,556 | 877 | |
Jun 07 2021 | MLAB | MESA LABORATORIES ... | KELLY DAVID M | Director | Option Exercise | X | 70.56 | 189 | 13,336 | 1,077 | |
Jun 07 2021 | MLAB | MESA LABORATORIES ... | KELLY DAVID M | Director | Option Exercise | X | 70.56 | 189 | 13,336 | 1,077 | |
Jun 07 2021 | MLAB | MESA LABORATORIES ... | KELLY DAVID M | Director | Option Exercise | X | 89.70 | 172 | 15,428 | 1,266 | |
Jun 07 2021 | MLAB | MESA LABORATORIES ... | KELLY DAVID M | Director | Option Exercise | X | 89.70 | 172 | 15,428 | 1,266 | |
Jun 07 2021 | MLAB | MESA LABORATORIES ... | KELLY DAVID M | Director | Sell | S | 260.28 | 851 | 221,498 | 2,600 | 3.5 K to 2.6 K (-24.66 %) |
Jun 07 2021 | MLAB | MESA LABORATORIES ... | KELLY DAVID M | Director | Sell | S | 260.28 | 851 | 221,498 | 2,600 | 3.5 K to 2.6 K (-24.66 %) |
Jun 07 2021 | MLAB | MESA LABORATORIES ... | KELLY DAVID M | Director | Buy | M | 142.40 | 90 | 12,816 | 3,451 | 3.4 K to 3.5 K (+2.68 %) |
Jun 07 2021 | MLAB | MESA LABORATORIES ... | KELLY DAVID M | Director | Buy | M | 142.40 | 90 | 12,816 | 3,451 | 3.4 K to 3.5 K (+2.68 %) |
Jun 07 2021 | MLAB | MESA LABORATORIES ... | KELLY DAVID M | Director | Buy | M | 122.66 | 200 | 24,532 | 3,361 | 3.2 K to 3.4 K (+6.33 %) |
Jun 07 2021 | MLAB | MESA LABORATORIES ... | KELLY DAVID M | Director | Buy | M | 122.66 | 200 | 24,532 | 3,361 | 3.2 K to 3.4 K (+6.33 %) |
Jun 07 2021 | MLAB | MESA LABORATORIES ... | KELLY DAVID M | Director | Buy | M | 97.78 | 200 | 19,556 | 3,161 | 3 K to 3.2 K (+6.75 %) |
Jun 07 2021 | MLAB | MESA LABORATORIES ... | KELLY DAVID M | Director | Buy | M | 97.78 | 200 | 19,556 | 3,161 | 3 K to 3.2 K (+6.75 %) |
Jun 07 2021 | MLAB | MESA LABORATORIES ... | KELLY DAVID M | Director | Buy | M | 70.56 | 189 | 13,336 | 2,961 | 2.8 K to 3 K (+6.82 %) |
Jun 07 2021 | MLAB | MESA LABORATORIES ... | KELLY DAVID M | Director | Buy | M | 70.56 | 189 | 13,336 | 2,961 | 2.8 K to 3 K (+6.82 %) |
Jun 07 2021 | MLAB | MESA LABORATORIES ... | KELLY DAVID M | Director | Buy | M | 89.70 | 172 | 15,428 | 2,772 | 2.6 K to 2.8 K (+6.62 %) |
Jun 07 2021 | MLAB | MESA LABORATORIES ... | KELLY DAVID M | Director | Buy | M | 89.70 | 172 | 15,428 | 2,772 | 2.6 K to 2.8 K (+6.62 %) |
Jun 07 2021 | MLAB | MESA LABORATORIES ... | DINOIA GREGORY | SVP Commercial | Option Exercise | X | 142.40 | 540 | 76,896 | 5,914 | |
Jun 07 2021 | MLAB | MESA LABORATORIES ... | DINOIA GREGORY | SVP Commercial | Sell | S | 260.27 | 540 | 140,546 | 840 | 1.4 K to 840 (-39.13 %) |
Jun 07 2021 | MLAB | MESA LABORATORIES ... | DINOIA GREGORY | SVP Commercial | Buy | M | 142.40 | 540 | 76,896 | 1,380 | 840 to 1.4 K (+64.29 %) |
May 07 2021 | MLAB | MESA LABORATORIES ... | Sullivan John James | Director | Sell | S | 250.05 | 200 | 50,010 | 32,859 | 33.1 K to 32.9 K (-0.60 %) |
May 07 2021 | MLAB | MESA LABORATORIES ... | Sullivan John James | Director | Sell | S | 250.59 | 100 | 25,059 | 33,059 | 33.2 K to 33.1 K (-0.30 %) |
May 05 2021 | MLAB | MESA LABORATORIES ... | Sullivan John James | Director | Sell | S | 250.14 | 735 | 183,853 | 33,159 | 33.9 K to 33.2 K (-2.17 %) |
Apr 19 2021 | MLAB | MESA LABORATORIES ... | GUILLEMIN EVAN | Director | Sell | S | 253.77 | 720 | 182,714 | 31,315 | 32 K to 31.3 K (-2.25 %) |
Apr 12 2021 | MLAB | MESA LABORATORIES ... | Sullivan John James | Director | Gift | G | 0.00 | 23,564 | 0 | 23,564 | 0 to 23.6 K |
Apr 12 2021 | MLAB | MESA LABORATORIES ... | Sullivan John James | Director | Gift | G | 0.00 | 23,564 | 0 | 34,394 | 58 K to 34.4 K (-40.66 %) |
Mar 16 2021 | MLAB | MESA LABORATORIES ... | GUILLEMIN EVAN | Director | Sell | S | 269.48 | 720 | 194,026 | 32,035 | 32.8 K to 32 K (-2.20 %) |
Mar 15 2021 | MLAB | MESA LABORATORIES ... | Sakys John | CFO | Option Exercise | X | 70.56 | 2,000 | 141,120 | 32,496 | |
Mar 15 2021 | MLAB | MESA LABORATORIES ... | Sakys John | CFO | Option Exercise | X | 48.72 | 500 | 24,360 | 34,496 | |
Mar 15 2021 | MLAB | MESA LABORATORIES ... | Sakys John | CFO | Sell | S | 263.84 | 2,500 | 659,600 | 4,350 | 6.9 K to 4.4 K (-36.50 %) |
Mar 15 2021 | MLAB | MESA LABORATORIES ... | Sakys John | CFO | Buy | M | 70.56 | 2,000 | 141,120 | 6,850 | 4.9 K to 6.9 K (+41.24 %) |
Mar 15 2021 | MLAB | MESA LABORATORIES ... | Sakys John | CFO | Buy | M | 48.72 | 500 | 24,360 | 4,850 | 4.4 K to 4.9 K (+11.49 %) |
Mar 11 2021 | MLAB | MESA LABORATORIES ... | Archbold Brian David | SVP Continuous Impr ... | Option Exercise | X | 129.10 | 145 | 18,720 | 5,213 | |
Mar 11 2021 | MLAB | MESA LABORATORIES ... | Archbold Brian David | SVP Continuous Impr ... | Sell | S | 271.78 | 223 | 60,607 | 154 | 377 to 154 (-59.15 %) |
Mar 11 2021 | MLAB | MESA LABORATORIES ... | Archbold Brian David | SVP Continuous Impr ... | Buy | M | 129.10 | 145 | 18,720 | 377 | 232 to 377 (+62.50 %) |
Mar 02 2021 | MLAB | MESA LABORATORIES ... | Sullivan John James | Director | Sell | S | 273.94 | 1,250 | 342,425 | 57,958 | 59.2 K to 58 K (-2.11 %) |
Feb 24 2021 | MLAB | MESA LABORATORIES ... | DINOIA GREGORY | SVP Commericial | Sell | S | 276.75 | 280 | 77,490 | 840 | 1.1 K to 840 (-25.00 %) |
Feb 24 2021 | MLAB | MESA LABORATORIES ... | DINOIA GREGORY | SVP Commericial | Sell | S | 276.75 | 280 | 77,490 | 840 | 1.1 K to 840 (-25.00 %) |
Feb 17 2021 | MLAB | MESA LABORATORIES ... | GUILLEMIN EVAN | Director | Sell | S | 281.52 | 3,600 | 1,013,472 | 32,755 | 36.4 K to 32.8 K (-9.90 %) |
Feb 10 2021 | MLAB | MESA LABORATORIES ... | Schmieder John Bradley | Director | Sell | S | 278.23 | 1,750 | 486,903 | 71,717 | 73.5 K to 71.7 K (-2.38 %) |
Feb 01 2021 | MLAB | MESA LABORATORIES ... | Sullivan John James | Director | Sell | S | 277.67 | 1,250 | 347,088 | 59,208 | 60.5 K to 59.2 K (-2.07 %) |
Jan 12 2021 | MLAB | MESA LABORATORIES ... | Schmieder John Bradley | Director | Sell | S | 285.23 | 477 | 136,055 | 73,467 | 73.9 K to 73.5 K (-0.65 %) |
Jan 11 2021 | MLAB | MESA LABORATORIES ... | Sakys John | CFO | Option Exercise | X | 89.70 | 1,000 | 89,700 | 34,996 | |
Jan 11 2021 | MLAB | MESA LABORATORIES ... | Sakys John | CFO | Buy | M | 89.70 | 1,000 | 89,700 | 4,350 | 3.4 K to 4.4 K (+29.85 %) |
Jan 07 2021 | MLAB | MESA LABORATORIES ... | Sakys John | CFO | Option Exercise | X | 89.70 | 16 | 1,435 | 35,996 | |
Jan 07 2021 | MLAB | MESA LABORATORIES ... | Sakys John | CFO | Sell | S | 290.00 | 16 | 4,640 | 3,350 | 3.4 K to 3.4 K (-0.48 %) |
Jan 07 2021 | MLAB | MESA LABORATORIES ... | Sakys John | CFO | Buy | M | 89.70 | 16 | 1,435 | 3,366 | 3.4 K to 3.4 K (+0.48 %) |
Jan 04 2021 | MLAB | MESA LABORATORIES ... | Sullivan John James | Director | Sell | S | 280.82 | 1,250 | 351,025 | 60,458 | 61.7 K to 60.5 K (-2.03 %) |
Dec 14 2020 | MLAB | MESA LABORATORIES ... | KELLY DAVID M | Director | Sell | S | 283.18 | 250 | 70,795 | 2,350 | 2.6 K to 2.4 K (-9.62 %) |
Nov 18 2020 | MLAB | MESA LABORATORIES ... | Sakys John | CFO | Option Exercise | X | 89.70 | 984 | 88,265 | 36,012 | |
Nov 18 2020 | MLAB | MESA LABORATORIES ... | Sakys John | CFO | Sell | S | 290.00 | 984 | 285,360 | 3,350 | 4.3 K to 3.4 K (-22.70 %) |
Nov 18 2020 | MLAB | MESA LABORATORIES ... | Sakys John | CFO | Buy | M | 89.70 | 984 | 88,265 | 4,334 | 3.4 K to 4.3 K (+29.37 %) |
Nov 18 2020 | MLAB | MESA LABORATORIES ... | KELLY DAVID M | Director | Option Exercise | X | 58.51 | 17 | 995 | 1,438 | |
Nov 18 2020 | MLAB | MESA LABORATORIES ... | KELLY DAVID M | Director | Sell | S | 283.31 | 704 | 199,450 | 2,600 | 3.3 K to 2.6 K (-21.31 %) |
Nov 18 2020 | MLAB | MESA LABORATORIES ... | KELLY DAVID M | Director | Buy | M | 58.51 | 17 | 995 | 3,304 | 3.3 K to 3.3 K (+0.52 %) |
Nov 16 2020 | MLAB | MESA LABORATORIES ... | GUILLEMIN EVAN | Director | Option Exercise | M | 0.00 | 477 | 0 | 0 | |
Nov 16 2020 | MLAB | MESA LABORATORIES ... | GUILLEMIN EVAN | Director | Option Exercise | A | 0.00 | 308 | 0 | 308 | |
Nov 16 2020 | MLAB | MESA LABORATORIES ... | GUILLEMIN EVAN | Director | Buy | M | 0.00 | 477 | 0 | 36,355 | 35.9 K to 36.4 K (+1.33 %) |
Nov 16 2020 | MLAB | MESA LABORATORIES ... | KELLY DAVID M | Director | Option Exercise | M | 0.00 | 477 | 0 | 0 | |
Nov 16 2020 | MLAB | MESA LABORATORIES ... | KELLY DAVID M | Director | Option Exercise | A | 0.00 | 308 | 0 | 308 | |
Nov 16 2020 | MLAB | MESA LABORATORIES ... | KELLY DAVID M | Director | Buy | M | 0.00 | 477 | 0 | 3,287 | 2.8 K to 3.3 K (+16.98 %) |
Nov 16 2020 | MLAB | MESA LABORATORIES ... | Alltoft Jennifer Sadie | Director | Option Exercise | M | 0.00 | 477 | 0 | 0 | |
Nov 16 2020 | MLAB | MESA LABORATORIES ... | Alltoft Jennifer Sadie | Director | Option Exercise | A | 0.00 | 308 | 0 | 308 | |
Nov 16 2020 | MLAB | MESA LABORATORIES ... | Alltoft Jennifer Sadie | Director | Buy | M | 0.00 | 477 | 0 | 686 | 209 to 686 (+228.23 %) |
Nov 16 2020 | MLAB | MESA LABORATORIES ... | Hall Shannon | Director | Option Exercise | M | 0.00 | 254 | 0 | 0 | |
Nov 16 2020 | MLAB | MESA LABORATORIES ... | Hall Shannon | Director | Option Exercise | A | 0.00 | 308 | 0 | 308 | |
Nov 16 2020 | MLAB | MESA LABORATORIES ... | Hall Shannon | Director | Buy | M | 0.00 | 254 | 0 | 254 | 0 to 254 |
Nov 13 2020 | MLAB | MESA LABORATORIES ... | GUILLEMIN EVAN | Director | Option Exercise | X | 51.85 | 800 | 41,480 | 5,090 | |
Nov 13 2020 | MLAB | MESA LABORATORIES ... | GUILLEMIN EVAN | Director | Option Exercise | X | 29.30 | 150 | 4,395 | 5,890 | |
Nov 13 2020 | MLAB | MESA LABORATORIES ... | GUILLEMIN EVAN | Director | Sell | S | 273.77 | 950 | 260,082 | 35,878 | 36.8 K to 35.9 K (-2.58 %) |
Nov 13 2020 | MLAB | MESA LABORATORIES ... | GUILLEMIN EVAN | Director | Buy | M | 51.85 | 800 | 41,480 | 36,828 | 36 K to 36.8 K (+2.22 %) |
Nov 13 2020 | MLAB | MESA LABORATORIES ... | GUILLEMIN EVAN | Director | Buy | M | 29.20 | 150 | 4,380 | 36,028 | 35.9 K to 36 K (+0.42 %) |
Nov 10 2020 | MLAB | MESA LABORATORIES ... | Archbold Brian David | SVP Continuous Impr ... | Option Exercise | X | 203.54 | 533 | 108,487 | 5,358 | |
Nov 10 2020 | MLAB | MESA LABORATORIES ... | Archbold Brian David | SVP Continuous Impr ... | Sell | S | 272.11 | 533 | 145,035 | 232 | 765 to 232 (-69.67 %) |
Nov 10 2020 | MLAB | MESA LABORATORIES ... | Archbold Brian David | SVP Continuous Impr ... | Buy | M | 203.54 | 533 | 108,487 | 765 | 232 to 765 (+229.74 %) |
Oct 09 2020 | MLAB | MESA LABORATORIES ... | Sakys John | CFO | Option Exercise | X | 89.70 | 942 | 84,497 | 36,996 | |
Oct 09 2020 | MLAB | MESA LABORATORIES ... | Sakys John | CFO | Sell | S | 276.90 | 942 | 260,840 | 3,350 | 4.3 K to 3.4 K (-21.95 %) |
Oct 09 2020 | MLAB | MESA LABORATORIES ... | Sakys John | CFO | Buy | M | 89.70 | 942 | 84,497 | 4,292 | 3.4 K to 4.3 K (+28.12 %) |
Oct 09 2020 | MLAB | MESA LABORATORIES ... | Owens Gary M | President and CEO | Sell | S | 276.91 | 323 | 89,442 | 9,863 | 10.2 K to 9.9 K (-3.17 %) |
Oct 09 2020 | MLAB | MESA LABORATORIES ... | Owens Gary M | President and CEO | Sell | S | 275.00 | 677 | 186,175 | 10,186 | 10.9 K to 10.2 K (-6.23 %) |
Sep 17 2020 | MLAB | MESA LABORATORIES ... | Owens Gary M | President and CEO | Option Exercise | M | 0.00 | 1,720 | 0 | 0 | |
Sep 17 2020 | MLAB | MESA LABORATORIES ... | Owens Gary M | President and CEO | Sell | S | 249.32 | 100 | 24,932 | 11,863 | 12 K to 11.9 K (-0.84 %) |
Sep 17 2020 | MLAB | MESA LABORATORIES ... | Owens Gary M | President and CEO | Payment of Exercise | F | 246.48 | 757 | 186,585 | 11,963 | 12.7 K to 12 K (-5.95 %) |
Sep 17 2020 | MLAB | MESA LABORATORIES ... | Owens Gary M | President and CEO | Buy | M | 0.00 | 1,720 | 0 | 12,720 | 11 K to 12.7 K (+15.64 %) |
Sep 08 2020 | MLAB | MESA LABORATORIES ... | DINOIA GREGORY | SVP Commerical | Sell | S | 243.55 | 280 | 68,194 | 1,182 | 1.5 K to 1.2 K (-19.15 %) |
Sep 04 2020 | MLAB | MESA LABORATORIES ... | Sakys John | CFO | Option Exercise | X | 48.72 | 702 | 34,201 | 37,938 | |
Sep 04 2020 | MLAB | MESA LABORATORIES ... | Sakys John | CFO | Option Exercise | X | 48.72 | 298 | 14,519 | 38,640 | |
Sep 04 2020 | MLAB | MESA LABORATORIES ... | Sakys John | CFO | Gift | G | 0.00 | 50 | 0 | 3,350 | 3.4 K to 3.4 K (-1.47 %) |
Sep 04 2020 | MLAB | MESA LABORATORIES ... | Sakys John | CFO | Sell | S | 251.42 | 702 | 176,497 | 3,400 | 4.1 K to 3.4 K (-17.11 %) |
Sep 04 2020 | MLAB | MESA LABORATORIES ... | Sakys John | CFO | Buy | M | 48.72 | 702 | 34,201 | 4,102 | 3.4 K to 4.1 K (+20.65 %) |
Sep 04 2020 | MLAB | MESA LABORATORIES ... | Sakys John | CFO | Sell | S | 250.00 | 298 | 74,500 | 3,400 | 3.7 K to 3.4 K (-8.06 %) |
Sep 04 2020 | MLAB | MESA LABORATORIES ... | Sakys John | CFO | Buy | M | 48.72 | 298 | 14,519 | 3,698 | 3.4 K to 3.7 K (+8.76 %) |
Sep 02 2020 | MLAB | MESA LABORATORIES ... | KELLY DAVID M | Director | Option Exercise | X | 122.66 | 600 | 73,596 | 1,455 | |
Sep 02 2020 | MLAB | MESA LABORATORIES ... | KELLY DAVID M | Director | Option Exercise | X | 142.40 | 180 | 25,632 | 2,055 | |
Sep 02 2020 | MLAB | MESA LABORATORIES ... | KELLY DAVID M | Director | Sell | S | 245.00 | 600 | 147,000 | 2,810 | 3.4 K to 2.8 K (-17.60 %) |
Sep 02 2020 | MLAB | MESA LABORATORIES ... | KELLY DAVID M | Director | Buy | M | 122.66 | 600 | 73,596 | 3,410 | 2.8 K to 3.4 K (+21.35 %) |
Sep 02 2020 | MLAB | MESA LABORATORIES ... | KELLY DAVID M | Director | Sell | S | 244.00 | 180 | 43,920 | 2,810 | 3 K to 2.8 K (-6.02 %) |
Sep 02 2020 | MLAB | MESA LABORATORIES ... | KELLY DAVID M | Director | Buy | M | 142.40 | 180 | 25,632 | 2,990 | 2.8 K to 3 K (+6.41 %) |
Aug 18 2020 | MLAB | MESA LABORATORIES ... | KELLY DAVID M | Director | Option Exercise | X | 97.78 | 800 | 78,224 | 2,235 | |
Aug 18 2020 | MLAB | MESA LABORATORIES ... | KELLY DAVID M | Director | Sell | S | 247.72 | 800 | 198,176 | 2,810 | 3.6 K to 2.8 K (-22.16 %) |
Aug 18 2020 | MLAB | MESA LABORATORIES ... | KELLY DAVID M | Director | Buy | M | 97.78 | 800 | 78,224 | 3,610 | 2.8 K to 3.6 K (+28.47 %) |
Aug 18 2020 | MLAB | MESA LABORATORIES ... | DINOIA GREGORY | SVP Commercial | Option Exercise | X | 203.54 | 783 | 159,372 | 6,724 | |
Aug 18 2020 | MLAB | MESA LABORATORIES ... | DINOIA GREGORY | SVP Commercial | Sell | S | 245.70 | 835 | 205,160 | 1,462 | 2.3 K to 1.5 K (-36.35 %) |
Aug 18 2020 | MLAB | MESA LABORATORIES ... | DINOIA GREGORY | SVP Commercial | Buy | M | 203.54 | 783 | 159,372 | 2,297 | 1.5 K to 2.3 K (+51.72 %) |
Aug 17 2020 | MLAB | MESA LABORATORIES ... | Sakys John | CFO | Option Exercise | X | 48.72 | 1,000 | 48,720 | 38,938 | |
Aug 17 2020 | MLAB | MESA LABORATORIES ... | Sakys John | CFO | Gift | G | 0.00 | 100 | 0 | 3,400 | 3.5 K to 3.4 K (-2.86 %) |
Aug 17 2020 | MLAB | MESA LABORATORIES ... | Sakys John | CFO | Sell | S | 244.00 | 1,000 | 244,000 | 3,500 | 4.5 K to 3.5 K (-22.22 %) |
Aug 17 2020 | MLAB | MESA LABORATORIES ... | Sakys John | CFO | Buy | M | 48.72 | 1,000 | 48,720 | 4,500 | 3.5 K to 4.5 K (+28.57 %) |
Aug 14 2020 | MLAB | MESA LABORATORIES ... | Schmieder John Bradley | Director | Option Exercise | X | 89.70 | 1,429 | 128,181 | 3,021 | |
Aug 14 2020 | MLAB | MESA LABORATORIES ... | Schmieder John Bradley | Director | Sell | S | 246.29 | 1,429 | 351,948 | 73,467 | 74.9 K to 73.5 K (-1.91 %) |
Aug 14 2020 | MLAB | MESA LABORATORIES ... | Schmieder John Bradley | Director | Buy | M | 72.02 | 1,429 | 102,917 | 74,896 | 73.5 K to 74.9 K (+1.95 %) |
Aug 13 2020 | MLAB | MESA LABORATORIES ... | Archbold Brian David | SVP Continuous Impr ... | Option Exercise | X | 142.40 | 420 | 59,808 | 5,891 | |
Aug 13 2020 | MLAB | MESA LABORATORIES ... | Archbold Brian David | SVP Continuous Impr ... | Option Exercise | X | 129.10 | 145 | 18,720 | 6,311 | |
Aug 13 2020 | MLAB | MESA LABORATORIES ... | Archbold Brian David | SVP Continuous Impr ... | Sell | S | 250.00 | 38 | 9,500 | 232 | 270 to 232 (-14.07 %) |
Aug 13 2020 | MLAB | MESA LABORATORIES ... | Archbold Brian David | SVP Continuous Impr ... | Sell | S | 250.00 | 420 | 105,000 | 270 | 690 to 270 (-60.87 %) |
Aug 13 2020 | MLAB | MESA LABORATORIES ... | Archbold Brian David | SVP Continuous Impr ... | Buy | M | 142.40 | 420 | 59,808 | 690 | 270 to 690 (+155.56 %) |
Aug 13 2020 | MLAB | MESA LABORATORIES ... | Archbold Brian David | SVP Continuous Impr ... | Sell | S | 250.00 | 145 | 36,250 | 270 | 415 to 270 (-34.94 %) |
Aug 13 2020 | MLAB | MESA LABORATORIES ... | Archbold Brian David | SVP Continuous Impr ... | Buy | M | 129.10 | 145 | 18,720 | 415 | 270 to 415 (+53.70 %) |
Aug 13 2020 | MLAB | MESA LABORATORIES ... | KELLY DAVID M | Director | Option Exercise | X | 70.56 | 942 | 66,468 | 3,035 | |
Aug 13 2020 | MLAB | MESA LABORATORIES ... | KELLY DAVID M | Director | Option Exercise | X | 58.51 | 85 | 4,973 | 3,977 | |
Aug 13 2020 | MLAB | MESA LABORATORIES ... | KELLY DAVID M | Director | Option Exercise | X | 89.70 | 344 | 30,857 | 4,062 | |
Aug 13 2020 | MLAB | MESA LABORATORIES ... | KELLY DAVID M | Director | Sell | S | 250.00 | 942 | 235,500 | 2,810 | 3.8 K to 2.8 K (-25.11 %) |
Aug 13 2020 | MLAB | MESA LABORATORIES ... | KELLY DAVID M | Director | Buy | M | 70.56 | 942 | 66,468 | 3,752 | 2.8 K to 3.8 K (+33.52 %) |
Aug 13 2020 | MLAB | MESA LABORATORIES ... | KELLY DAVID M | Director | Sell | S | 250.00 | 85 | 21,250 | 2,810 | 2.9 K to 2.8 K (-2.94 %) |
Aug 13 2020 | MLAB | MESA LABORATORIES ... | KELLY DAVID M | Director | Buy | M | 58.51 | 85 | 4,973 | 2,895 | 2.8 K to 2.9 K (+3.02 %) |
Aug 13 2020 | MLAB | MESA LABORATORIES ... | KELLY DAVID M | Director | Sell | S | 250.00 | 344 | 86,000 | 2,810 | 3.2 K to 2.8 K (-10.91 %) |
Aug 13 2020 | MLAB | MESA LABORATORIES ... | KELLY DAVID M | Director | Buy | M | 89.70 | 344 | 30,857 | 3,154 | 2.8 K to 3.2 K (+12.24 %) |
Jun 17 2020 | MLAB | MESA LABORATORIES ... | Sakys John | CFO | Option Exercise | A | 0.00 | 681 | 0 | 681 | |
Jun 17 2020 | MLAB | MESA LABORATORIES ... | Sakys John | CFO | Option Exercise | A | 226.72 | 3,951 | 895,771 | 39,938 | |
Jun 17 2020 | MLAB | MESA LABORATORIES ... | Sakys John | CFO | Option Exercise | A | 0.00 | 1,189 | 0 | 1,189 | |
Jun 17 2020 | MLAB | MESA LABORATORIES ... | DINOIA GREGORY | SVP Commecial Opera ... | Option Exercise | A | 0.00 | 559 | 0 | 559 | |
Jun 17 2020 | MLAB | MESA LABORATORIES ... | DINOIA GREGORY | SVP Commecial Opera ... | Option Exercise | A | 226.72 | 3,026 | 686,055 | 7,507 | |
Jun 17 2020 | MLAB | MESA LABORATORIES ... | DINOIA GREGORY | SVP Commecial Opera ... | Option Exercise | A | 0.00 | 911 | 0 | 911 | |
Jun 17 2020 | MLAB | MESA LABORATORIES ... | DINOIA GREGORY | SVP Commecial Opera ... | Option Exercise | M | 0.00 | 90 | 0 | 270 | |
Jun 17 2020 | MLAB | MESA LABORATORIES ... | DINOIA GREGORY | SVP Commecial Opera ... | Payment of Exercise | F | 226.72 | 38 | 8,615 | 1,514 | 1.6 K to 1.5 K (-2.45 %) |
Jun 17 2020 | MLAB | MESA LABORATORIES ... | DINOIA GREGORY | SVP Commecial Opera ... | Buy | M | 0.00 | 90 | 0 | 1,552 | 1.5 K to 1.6 K (+6.16 %) |
Jun 17 2020 | MLAB | MESA LABORATORIES ... | Archbold Brian David | SVP Continuous Impr ... | Option Exercise | A | 0.00 | 419 | 0 | 419 | |
Jun 17 2020 | MLAB | MESA LABORATORIES ... | Archbold Brian David | SVP Continuous Impr ... | Option Exercise | A | 226.72 | 2,697 | 611,464 | 6,456 | |
Jun 17 2020 | MLAB | MESA LABORATORIES ... | Archbold Brian David | SVP Continuous Impr ... | Option Exercise | A | 0.00 | 812 | 0 | 812 | |
Jun 17 2020 | MLAB | MESA LABORATORIES ... | Archbold Brian David | SVP Continuous Impr ... | Option Exercise | M | 0.00 | 70 | 0 | 210 |